WTR Healthcare Happenings

In this episode of WTR Healthcare Happenings, Robert Sassoon, Managing Director and Healthcare Analyst at Water Tower Research, joins host Tim Gerdeman, Co-Founder of Water Tower Research, to discuss his newly published initiation of coverage on PharmAla Biotech Holdings (CSE: MDMA, OTCQB: MDXX). Robert Sassoon explains how the Toronto-based company built two businesses on a single chemical and regulatory foundation: a commercial supply business shipping clinical-grade GMP MDMA under the Linn...

In this episode of WTR Healthcare Happenings, Robert Sassoon, Managing Director of Healthcare Equity Research at Water Tower Research, joins host Tim Gerdeman to discuss his newly published initiation of coverage on Circular Genomics, a privately held molecular diagnostics company developing blood-based tests using circular RNA (circRNA) biomarkers. Robert Sassoon explains the science behind circRNA and discusses the company’s Alzheimer’s research published in Nature Medicine in July, includi...

In this episode of WTR Healthcare Happenings, Robert Sassoon, Managing Director and healthcare analyst at Water Tower Research, joins host Tim Gerdeman to discuss his newly published initiation of coverage on eXoZymes (Nasdaq: EXOZ) and its cell-free biomanufacturing platform. Robert Sassoon explains how the technology works, the significance of the reported 10-fold productivity improvement in NCT manufacturing, and the next steps toward validating commercial-scale production with CDMO partne...

In this episode of WTR Healthcare Happenings, Kirk Huntsman, CEO of Vivos Therapeutics (NASDAQ: VVOS), joins WTR healthcare analyst Robert Sassoon and host Tim Gerdeman to break down the company's financial and operational restructuring. Kirk Huntsman details the work underway to strengthen the balance sheet, including debt reduction, equity requirements, and Nasdaq compliance. The conversation then turns to the operational turnaround, covering rising patient referrals, expanded capacity in N...

In this episode of WTR Healthcare Happenings, Natural MedTech CEO and Co-Founder Luke McFarlane joins WTR healthcare analyst Robert Sassoon and Shawn Severson to discuss the company's biosynthetic psilocybin manufacturing platform and its position within Australia's evolving psychedelic medicine landscape. The conversation covers the authorized prescriber pathway, including adoption trends, treatment costs, regulatory developments, and early insurer engagement. McFarlane walks through NMT's p...